Paul A Mahon is EVP & GENERAL COUNSEL of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 36,781 shares of UTHR, which is worth approximately $11.1 Million. The most recent transaction as insider was on Aug 07, 2025, when has been sold 11,000 shares (Common Stock) at a price of $300.57 per share, resulting in proceeds of $3,306,270. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.8K
0% 3M change
0.19% 12M change
Total Value Held $11.1 Million

PAUL A MAHON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 07 2025
SELL
Open market or private sale
$3,306,270 $300.57 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
Aug 07 2025
BUY
Exercise of conversion of derivative security
$1,489,619 $135.42 p/Share
11,000 Added 18.71%
47,781 Common Stock
Jul 24 2025
SELL
Open market or private sale
$3,346,530 $304.23 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
Jul 24 2025
BUY
Exercise of conversion of derivative security
$1,489,619 $135.42 p/Share
11,000 Added 18.71%
47,781 Common Stock
Jul 10 2025
SELL
Open market or private sale
$3,297,470 $299.77 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
Jul 10 2025
BUY
Exercise of conversion of derivative security
$1,489,619 $135.42 p/Share
11,000 Added 18.71%
47,781 Common Stock
Jun 26 2025
SELL
Open market or private sale
$3,151,829 $286.53 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
Jun 26 2025
BUY
Exercise of conversion of derivative security
$1,489,619 $135.42 p/Share
11,000 Added 18.71%
47,781 Common Stock
Jun 12 2025
SELL
Open market or private sale
$3,072,739 $279.34 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
Jun 12 2025
BUY
Exercise of conversion of derivative security
$1,489,619 $135.42 p/Share
11,000 Added 18.71%
47,781 Common Stock
May 29 2025
SELL
Open market or private sale
$3,464,340 $314.94 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
May 29 2025
BUY
Exercise of conversion of derivative security
$1,392,490 $126.59 p/Share
11,000 Added 18.71%
47,781 Common Stock
May 15 2025
SELL
Open market or private sale
$3,268,870 $297.17 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
May 15 2025
BUY
Exercise of conversion of derivative security
$1,295,360 $117.76 p/Share
11,000 Added 18.71%
47,781 Common Stock
May 01 2025
SELL
Open market or private sale
$3,292,410 $299.31 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
May 01 2025
BUY
Exercise of conversion of derivative security
$1,295,360 $117.76 p/Share
11,000 Added 18.71%
47,781 Common Stock
Apr 17 2025
SELL
Open market or private sale
$3,112,450 $282.95 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
Apr 17 2025
BUY
Exercise of conversion of derivative security
$1,295,360 $117.76 p/Share
11,000 Added 18.71%
47,781 Common Stock
Apr 03 2025
SELL
Open market or private sale
$3,345,430 $304.13 p/Share
11,000 Reduced 23.02%
36,781 Common Stock
Apr 03 2025
BUY
Exercise of conversion of derivative security
$1,295,360 $117.76 p/Share
11,000 Added 18.71%
47,781 Common Stock
Mar 06 2025
SELL
Sale (or disposition) back to the issuer
$2,015,304 $307.68 p/Share
6,550 Reduced 15.12%
36,781 Common Stock
Mar 06 2025
BUY
Exercise of conversion of derivative security
$1,069,615 $163.3 p/Share
6,550 Added 13.13%
43,331 Common Stock
Feb 20 2025
SELL
Sale (or disposition) back to the issuer
$2,828,672 $367.36 p/Share
7,700 Reduced 17.34%
36,710 Common Stock
Feb 20 2025
BUY
Exercise of conversion of derivative security
$1,257,410 $163.3 p/Share
7,700 Added 14.78%
44,410 Common Stock
Feb 06 2025
SELL
Sale (or disposition) back to the issuer
$2,723,875 $353.75 p/Share
7,700 Reduced 17.34%
36,710 Common Stock
PAM

Paul A Mahon

EVP & GENERAL COUNSEL
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR